There must be a way out of here: identifying a safe and efficient combination of promoter, transgene, and vector backbone for gene therapy of neurological disease. [electronic resource]
- Molecular therapy : the journal of the American Society of Gene Therapy Feb 2014
- 246-247 p. digital